PROTAC CDK9 degrader-2
Based on 1 Customer Validation
PROTAC CDK9 degrader-2 is a PROTAC degrader targeting CDK9, with an IC50 of 523 nM. PROTAC CDK9 degrader-2 selectively degrades CDK9 via the cereblon-dependent ubiquitin-proteasome pathway and inhibits the proliferation of cancer cells overexpressing CDK9. PROTAC CDK9 degrader-2 can be used for cancer research.
(Pink: CDK9 ligand (HY-N0400); Blue: Cereblon ligand (HY-10984); Black: linker).
For research use only. We do not sell to patients.
- Purity: 99.22%
- CAS No.: 2435721-30-3
- Formula: C39H36N6O10
- Molecular Weight:748.74
-
Storage:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
All PROTACs Isoforms
More
Biological Activity
|
CDK9 523 nM (IC50) |
CDK9 17 μM (IC50, MCF-7 cells) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF7 | IC50 |
17 μM
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
30196207 |
| L02 | IC50 |
> 100 μM
|
Antiproliferative activity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Antiproliferative activity against human L02 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
30196207 |
PROTAC CDK9 degrader-2 (compound 11c) (1-30 μM, 24 h) selectively induces concentration-dependent, proteasome-dependent, and CRBN-dependent degradation of CDK9 and its downstream Mcl-1 protein in MCF-7 cells[1].
PROTAC CDK9 degrader-2 (72 h) selectively inhibits the proliferation of MCF-7 cells with overexpressed CDK9, with an IC50 of 17 μM, while its activity against L02 cells with low CDK9 expression is negligible[1].
PROTAC CDK9 degrader-2 (10-20 μM; 24 h) induces dose-dependent apoptosis in MCF-7 cells following incubation at concentrations of 10 μM and 20 μM for 24 h[1].
PROTAC CDK9 degrader-2 (1 μM; 1 h) potently inhibits the kinase activity of recombinant CDK9/CycT1, with an IC50 value of 523 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 human breast cancer cells
-
Concentration:1, 10, 30 μM
-
Incubation Time:24, 72 h
-
Result:Induced concentration-dependent degradation of intracellular CDK9 protein, with no detectable effect on CDK2, CDK4, CDK5, CDK7, or CDK8 levels.
Caused concentration-dependent reduction of Mcl-1 protein levels.
Blocked Mcl-1 reduction when cells were pre-treated with MG132.
Reduced degradation of both CDK9 and Mcl-1 when cells were transfected with CRBN siRNA.
-
Cell Line:MCF-7 human breast cancer cells
-
Concentration:10, 20 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in a dose-dependent manner, with apoptotic cell populations increasing with higher concentrations of the compound.
Chemical Information
-
CAS No. 2435721-30-3
-
Appearance Solid
-
Molecular Weight 748.74
-
Formula C39H36N6O10
-
Color Light yellow to yellow
-
SMILES
O=C(C=C(C1=CC=CC=C1)O2)C3=C2C(OCC4=CN(CCCCCCCC(NC5=C(C(N(C6C(NC(CC6)=O)=O)C7=O)=O)C7=CC=C5)=O)N=N4)=C(O)C=C3O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility
DMSO : 100 mg/mL (133.56 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.3356 mL | 6.6779 mL | 13.3558 mL | 33.3894 mL |
| 5 mM | 0.2671 mL | 1.3356 mL | 2.6712 mL | 6.6779 mL | |
| 10 mM | 0.1336 mL | 0.6678 mL | 1.3356 mL | 3.3389 mL | |
| 15 mM | 0.0890 mL | 0.4452 mL | 0.8904 mL | 2.2260 mL | |
| 20 mM | 0.0668 mL | 0.3339 mL | 0.6678 mL | 1.6695 mL | |
| 25 mM | 0.0534 mL | 0.2671 mL | 0.5342 mL | 1.3356 mL | |
| 30 mM | 0.0445 mL | 0.2226 mL | 0.4452 mL | 1.1130 mL | |
| 40 mM | 0.0334 mL | 0.1669 mL | 0.3339 mL | 0.8347 mL | |
| 50 mM | 0.0267 mL | 0.1336 mL | 0.2671 mL | 0.6678 mL | |
| 60 mM | 0.0223 mL | 0.1113 mL | 0.2226 mL | 0.5565 mL | |
| 80 mM | 0.0167 mL | 0.0835 mL | 0.1669 mL | 0.4174 mL | |
| 100 mM | 0.0134 mL | 0.0668 mL | 0.1336 mL | 0.3339 mL |